Oppenheimer adjusted its outlook on Albemarle Corporation (NYSE:ALB), a global developer of lithium and other chemical solutions. The firm's analyst, Colin W. Rusch, reduced the price target to $123 ...
13h
Hosted on MSNAlbemarle's Earnings Are In-Is the Stock a Buy Now?Investors are typically – and justifiably – careful about investing in any given stock around the company’s earnings season ...
Truist analyst Peter Osterland lowered the firm’s price target on Albemarle (ALB) to $85 from $96 and keeps a Hold rating on the shares after ...
2d
Zacks.com on MSNAlbemarle (ALB) Reports Q4 Loss, Misses Revenue EstimatesAlbemarle (ALB) delivered earnings and revenue surprises of -122.45% and 6.08%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (NYSE:ALB – Get Free Report) will likely be posting its quarterly earnings results after the market closes on ...
Retirement Systems of Alabama decreased its stake in Albemarle Co. (NYSE:ALB – Free Report) by 2.5% during the 4th quarter, ...
CHARLOTTE, N.C. (AP) — CHARLOTTE, N.C. (AP) — Albemarle Corp. (ALB) on Wednesday reported fourth-quarter net income of $75.3 million, after reporting a loss in the same period a year earlier.
Albemarle (NYSE:ALB) is a specialty chemicals global producer that underwent a significant transformation over the years, becoming heavily affiliated with the lithium market as it became the ...
Lithium heavyweight Albemarle will mothball one of its processing plants in China as it continues cost-cutting measures that ...
During this period, the Zacks Chemical - Diversified industry, which Albemarle falls in, has lost 5.5%. The key question now is: What could be the stock's future direction? While media releases or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results